Home Drug Codes J Codes J7353 · NEXOBRID
Updated July 1st, 2026

NEXOBRID J Code: J7353

Anacaulase-bcdb, 8.8% gel, 1 gram

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Anacaulase-bcdb, 8.8% gel, 1 gram
HCPCS Added Date October 1, 2023
Manufacturer Vericel Corporation
Route of Administration Topical
Generic Status Single-Source; Branded
Dosage Form Kit

About NEXOBRID

Nexobrid is a medication aligned to the HCPCS J Code: J7353 for billing, pricing, and reimbursement purposes in the United States. This Wound Care medication is administered via the topical route and manufactured by Vericel Corporation.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J7353. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

NEXOBRID Pricing & Reimbursement

J7353 Private Payer Reimbursement
$57.78 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

NEXOBRID CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
97597 Debridement (e.g., high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (e.g., fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less.
97602 Removal of devitalized tissue from wound(s), non-selective debridement, without anesthesia (e.g., wet-to-moist dressings, enzymatic, abrasion), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session.
15002 Login for More Surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar (including subcutaneous tissues), or incisional release of scar contracture, trunk, arms, legs; first 100 sq cm or 1% of body area of infants and children. Login for More
15003 Login for More Surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar (including subcutaneous tissues), or incisional release of scar contracture, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet and/or multiple digits; each additional 100 sq cm or each additional 1% of body area of infants and children, or part thereof (List separately in addition to code for primary procedure). Login for More
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

NEXOBRID Medically Unlikely Edits (MUE)

The most billing units of J7353 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 gm (of 8.8% gel).

Practitioner Office & Hospital Outpatient
300 units / day
= 300 gm (of 8.8% gel) per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

gm (of 8.8% gel) Enter a dose to see how many billing units it is and whether it is under the limit.

NEXOBRID Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

eschar removal in deep partial thickness and/or full thickness thermal burns

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there a manufacturer-published billing and coding guide for Nexobrid?
Billing and coding information for NEXOBRID can be found through VERICEL CORPORATION. Visit Here →
Are there any available patient assistance programs for Nexobrid?
NEXOBRID patient assistance information can be found through VERICEL CORPORATION. Visit Here →
Where can I find Nexobrid prescribing information?
Nexobrid prescribing information can be found at the link below. Visit Here →
Is there available side effect information for Nexobrid?
Side effect information for Nexobrid can be found through Medline Plus at the link below. Visit Here →
Does billing NEXOBRID require JZ/JW wastage modifiers?
CMS does not include NEXOBRID (J7353) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7353. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.